Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-10-30

FDA Approved: SILENOR — Supplemental Application (Currax Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental NDA for Silenor (doxepin hydrochloride) by Currax Pharmaceuticals LLC. The approval relates to a change to the product labeling or i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silenor (Doxepin hydrochloride)

Snippet

SUPPL AP for SILENOR (DOXEPIN HYDROCHLORIDE)